InsidersTradesSigma
Qiagen N.V. Stock: price and insider trades · Netherlands · AFM
Track the Qiagen N.V. stock price and the full insider trade history of the company, a publicly traded company based in Netherlands. Shares trade on NL NL, under the authority of AFM. Operating in the Health Care sector, Qiagen N.V. has published 348 public disclosures. Market capitalisation: €8.3bn. The latest transaction was filed on 24 June 2026 (Mixed). Among the most active insiders: R. Sackers. The full history is free.
348
Insider Decl.
0
Thresholds
€1bn
90 ops.
Buy Volume
€187m
95 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Qiagen N.V. Buy (bullish), based on 14 analysts. Average price target: US$43.96.
25Σ signal
Fundamental score
Ranked 6,688 of 25,484 companies
63.6
score / 100
Value58
Quality70
FCF yld5.4%
Earn yld5.1%
EV/EBITDA14.1x
ROE12%
Gross mgn62%
Net mgn20%
Debt/EBITDA2.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 24 June 2026
Declarations348 total
29,150 sharesGewoon aandeelAFM:193942
Ideal exit: 13 Feb 2027 (T+270)
60,000 sharesGewoon aandeelAFM:193511
Ideal exit: 6 Feb 2027 (T+270)
-4,705 sharesRestricted share awardAFM:188999
-900 sharesRestricted share awardAFM:188993
-119,695 sharesRestricted share awardAFM:188984
-5,990 sharesRestricted share awardAFM:189031
-67,723 sharesRestricted share awardAFM:188955
-5,990 sharesRestricted share awardAFM:189028
-9,156 sharesRestricted share awardAFM:189030
-5,990 sharesRestricted share awardAFM:189026
4,618 sharesRestricted share awardAFM:189015
Ideal exit: 24 Nov 2026 (T+270)
4,618 sharesRestricted share awardAFM:189013
Ideal exit: 24 Nov 2026 (T+270)
70,305 sharesRestricted share awardAFM:189016
Ideal exit: 24 Nov 2026 (T+270)
4,618 sharesRestricted share awardAFM:189005
Ideal exit: 24 Nov 2026 (T+270)
4,618 sharesRestricted share awardAFM:189011
Ideal exit: 24 Nov 2026 (T+270)
4,618 sharesRestricted share awardAFM:189014
Ideal exit: 24 Nov 2026 (T+270)
-2,107 sharesRestricted share awardAFM:188861
25 of 348 declarations
About Qiagen N.V.
Qiagen N.V. is a company specializing in molecular biology technologies, providing solutions for diagnostics and research. It is listed on the Amsterdam Stock Exchange.
